PAMS
Pictet Asset Management (Switzerland)’s Moderna MRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $166M | Buy |
1,370,128
+56,453
| +4% | +$6.86M | 0.2% | 137 |
|
|
2023
Q1 | $202M | Buy |
1,313,675
+52,414
| +4% | +$8.05M | 0.25% | 119 |
|
|
2022
Q4 | $227M | Buy |
1,261,261
+901,274
| +250% | +$162M | 0.33% | 84 |
|
|
2022
Q3 | $42.6M | Buy |
359,987
+44,165
| +14% | +$5.22M | 0.06% | 293 |
|
|
2022
Q2 | $45.1M | Buy |
315,822
+72,730
| +30% | +$10.4M | 0.06% | 298 |
|
|
2022
Q1 | $41.9M | Sell |
243,092
-10,675
| -4% | -$1.84M | 0.05% | 346 |
|
|
2021
Q4 | $64.5M | Sell |
253,767
-3,851
| -1% | -$978K | 0.06% | 301 |
|
|
2021
Q3 | $99.1M | Buy |
+257,618
| New | +$99.1M | 0.11% | 226 |
|